Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 4/20 | 0.41 |
| ▸ | FDPS | P14324 | 4/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16079198 | 1.00 | SMPD1 (0.41) | SMPD1FDPSTSHRCES2THRB | |
| SCHEMBL8183289 | 1.00 | SMPD1 (0.41) | SMPD1FDPSTSHRCES2THRB | |
| SCHEMBL16079228 | 1.00 | SMPD1 (0.41) | SMPD1FDPSTSHRCES2THRB | |
| SCHEMBL27611849 | 1.00 | SMPD1 (0.41) | SMPD1FDPSTSHRCES2THRB | |
| SCHEMBL16084817 | 1.00 | SMPD1 (0.41) | SMPD1FDPSTSHRCES2THRB | |
| SCHEMBL27325293 | 0.98 | FDPS (0.39) | SMPD1FDPSTSHRCES2THRB | |
| SCHEMBL3834111 | 0.98 | FDPS (0.39) | SMPD1FDPSTSHRCES2THRB | |
| SCHEMBL8628270 | 0.96 | FDPS (0.38) | SMPD1FDPSTSHRCES2THRB | |
| SCHEMBL11700740 | 0.91 | — | — | |
| SCHEMBL6551648 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3656832-B1 | LIGAND-MODIFIED QUANTUM DOT COMPOSITION, LIGAND-MODIFIED QUANTUM DOT LAYER, PREPARATION METHOD THEREFOR, AND QUANTUM DOT LIGHT-EMITTING DIODE | BOE TECHNOLOGY GROUP CO LTD (CN) | 2023-06-21 | — | — | EP | disclosed |
| EP-3656832-A1 | LIGAND-MODIFIED QUANTUM DOT COMPOSITION, LIGAND-MODIFIED QUANTUM DOT LAYER, PREPARATION METHOD THEREFOR, AND QUANTUM DOT LIGHT-EMITTING DIODE | Boe Technology Group Co. Ltd. (CN) | 2020-05-27 | — | — | EP | disclosed |
| US-20190104732-A1 | Compounds, Compositions, and Methods for Altering Insect and Organism Behavior | BASF CORPORATION | 2019-04-11 | — | — | US | disclosed |
| US-20160029628-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR REPELLING AN INSECT FROM AN AREA,ARTICLE, AND/OR STRUCTURE | BAYER CROPSCIENCE LP (US) | 2016-02-04 | — | — | US | disclosed |
| US-9216999-B2 | Substituted pyrrolo[2,3-h][1,6]naphthyridines and compositions thereof as JAK inhibitors | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-12-22 | — | — | US | disclosed |
| US-20150257384-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR ALTERING INSECT AND ORGANISM BEHAVIOR | BASF CORPORATION | 2015-09-17 | — | — | US | disclosed |
| US-20140274683-A1 | COMPOSITIONS AND METHODS FOR REPELLING POLLINATING INSECTS AND PROTECTING PLANTS AND CROPS AGAINST INSECTS AND/OR NEMATODES | BAYER CROPSCIENCE LP (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140274682-A1 | COMPOSITIONS AND METHODS FOR REDUCING DUST AND REPELLING, CONTROLLING, OR DIRECTING AN INSECT | BAYER CROPSCIENCE LP (US) | 2014-09-18 | — | — | US | disclosed |
| WO-2014146145-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR ALTERING INSECT AND ORGANISM BEHAVIOR | BAYER CROPSCIENCE LP (US) | 2014-09-18 | — | — | WO | disclosed |
| WO-2014146143-A2 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR REPELLING AN INSECT FROM AN AREA, ARTICLE, AND/OR STRUCTURE | BAYER CROPSCIENCE LP (US) | 2014-09-18 | — | — | WO | disclosed |
| WO-2006002067-A1 | COMPOSITION AND METHOD USING LOCAL APPLICATION OF LIPOPHILIC LATHYROGENS IN SUSTAINED RELEASE FORMULATIONS | CHVAPIL MILOS (US) | 2006-01-05 | — | — | WO | disclosed |
| US-20050276855-A1 | Composition and method using local application of lipophilic lathyrogens sustained release formulations | CHVAPIL MILOS | 2005-12-15 | — | — | US | disclosed |
| WO-2005034882-A2 | COMPOSITION AND METHOD TO TREAT SOLID TUMORS | CHVAPIL MILOS (US) | 2005-04-21 | — | — | WO | disclosed |
| US-20050080132-A1 | Composition and method to treat solid tumors | CHVAPIL MILOS (US) | 2005-04-14 | — | — | US | disclosed |
| EP-0847383-B1 | MULTI-COMPONENT LIQUID AZODINITRILE MIXTURES | DU PONT (US) | 2001-11-07 | — | — | EP | disclosed |
| EP-0847383-A1 | MULTI-COMPONENT LIQUID AZODINITRILE MIXTURES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1998-06-17 | — | — | EP | disclosed |
| US-5760192-A | FREE RADICAL, POLYMERIZATION CATALYSTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1998-06-02 | — | — | US | disclosed |
| WO-1997008137-A1 | MULTI-COMPONENT LIQUID AZODINITRILE MIXTURES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-03-06 | — | — | WO | disclosed |
| US-4061590-A | Catalyst composition of an azo nitrile mixture in an organic solvent | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-12-06 | — | — | US | disclosed |
| US-3987025-A | POLYMERIZATION INITIATORS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140274683-A1 | COMPOSITIONS AND METHODS FOR REPELLING POLLINATING INSECTS AND PROTECTING PLANTS AND CROPS AGAINST INSECTS AND/OR NEMATODES | ACHE, BCHE, MSL1 | SMPD1 1253/4885FDPS 1333/4885TSHR 4493/4885 |
| US-20160029628-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR REPELLING AN INSECT FROM AN AREA,ARTICLE, AND/OR STRUCTURE | ACHE, BCHE, SGMS1 | SMPD1 117/4885FDPS 1874/4885TSHR 4121/4885 |
| US-20050080132-A1 | Composition and method to treat solid tumors | CYP17A1, CYP19A1, LPXN | SMPD1 2978/4885FDPS 2278/4885TSHR 568/4885 |
| US-20140274682-A1 | COMPOSITIONS AND METHODS FOR REDUCING DUST AND REPELLING, CONTROLLING, OR DIRECTING AN INSECT | EXOSC9, VCL, DSTN | SMPD1 575/4885FDPS 2879/4885TSHR 4481/4885 |
| US-20150257384-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR ALTERING INSECT AND ORGANISM BEHAVIOR | ACHE, DDT, MGLL | SMPD1 521/4885FDPS 1145/4885TSHR 2908/4885 |
| US-20190104732-A1 | Compounds, Compositions, and Methods for Altering Insect and Organism Behavior | ACHE, DDT, MGLL | SMPD1 521/4885FDPS 1145/4885TSHR 2908/4885 |
| US-20050276855-A1 | Composition and method using local application of lipophilic lathyrogens sustained release formulations | SHBG, PLOD3, LPXN | SMPD1 4186/4885FDPS 3300/4885TSHR 1615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.